Back

Evaluation of adherence to cardiovascular treatment among hypertensive patients in africa: EIGHT study

30 August 2016 (17:42 - 17:51)
Organised by:
Congress Presentation Part of: Hypertension in special conditions Hypertension: regional and ethnic profiles ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Marie Antignac

Pitie Salpetriere Hospital AP-HP - INSERM PARCC - Paris, France, Paris (France)

9 More presentations in this session

Presentation thumbnail
Long-term outcome of surgically- and medically-treated primary aldosteronism (PA) in the PA Prevalence in hYpertensives (PAPY) Study
Professor G. Rossi (Padua, IT)
Abstract
Presentation thumbnail
Hypertensive crises treatment in the real-world: are anti-anxiety drugs effective anti-hypertensive agents?
Associate Professor S. Perlini (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Antihypertensive treatment and erectile dysfunction: a penile Doppler ultrasound study
Doctor N. Ioakeimidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Blood pressure and mortality outocomes in hypertnesive patients with mild chronic obstructive pulmonary disease.
Mr K. Bryniarski (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Urapidil is more effective than nitroglycerin in maintaining renal blood flow in patients with hypertensive urgencies.
Associate Professor Y. Lutay (Kiev, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension in special conditions

The Event

Event poster

ESC Congress 2016

30 August 2016 17:42 CET
You may be interested in
thumbnail
Congress Presentation
Assesment of adherence to therapeutic recommendations among patients with hypertension
15 June 2024
thumbnail
Congress Presentation
Prevalence, determinants, and time trends of LS7 Cardiovascular Health in the WHO African Region 2003 to 2022
30 August 2025
thumbnail
Congress Presentation
Introduction
30 August 2025
thumbnail
Congress Presentation
Salt substitutes and premature cardiovascular deaths in Africa: a modelling study
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources